Wahn V
Immun Infekt. 1984 Feb;12(1):51-5.
The continuous improvement of gammaglobulin preparations for intravenous use has lead to new potential therapeutic applications no longer based on the substitution of lacking specific antibodies. Especially high-dose administration may exert positive influences on pathologically altered immune functions. The theoretical basis and clinical facts are discussed.
静脉用丙种球蛋白制剂的不断改进带来了新的潜在治疗应用,这些应用不再基于替代缺乏的特异性抗体。特别是高剂量给药可能对病理改变的免疫功能产生积极影响。本文讨论了其理论基础和临床事实。